Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252372 | SCV000312302 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000252372 | SCV000843791 | benign | not specified | 2019-12-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085624 | SCV001016832 | likely benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2024-12-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001311796 | SCV001502110 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | SETX: BP4, BP7 |
Gene |
RCV001311796 | SCV002099681 | likely benign | not provided | 2021-04-02 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848032 | SCV002105151 | uncertain significance | Hereditary spastic paraplegia | 2016-12-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002321932 | SCV002606663 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000252372 | SCV005883461 | likely benign | not specified | 2024-12-16 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001311796 | SCV001807356 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001311796 | SCV001928883 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001311796 | SCV001974138 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001311796 | SCV002034404 | likely benign | not provided | no assertion criteria provided | clinical testing |